Trial · NCT03214081
Adverse events18
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 18 of 18
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Diarrhoea | Gastrointestinal disorders | Vonoprazan 10 mg or 20 mg | 11 | 1,174 | |
| serious | Pneumonia | Infections and infestations | Vonoprazan 10 mg or 20 mg | 2 | 1,174 | |
| serious | Peritonitis bacterial | Infections and infestations | Vonoprazan 10 mg or 20 mg | 1 | 1,174 | |
| serious | Acute Leukaemia | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Vonoprazan 10 mg or 20 mg | 1 | 1,174 | |
| serious | Lymphoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Vonoprazan 10 mg or 20 mg | 1 | 1,174 | |
| serious | Myelodysplastic syndrome | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Vonoprazan 10 mg or 20 mg | 1 | 1,174 | |
| serious | Hepatic cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Vonoprazan 10 mg or 20 mg | 1 | 1,174 | |
| serious | Myelopathy | Nervous system disorders | Vonoprazan 10 mg or 20 mg | 1 | 1,174 | |
| serious | Subarachnoid haemorrhage | Nervous system disorders | Vonoprazan 10 mg or 20 mg | 1 | 1,174 | |
| serious | Angina unstable | Cardiac disorders | Vonoprazan 10 mg or 20 mg | 1 | 1,174 | |
| serious | Respiratory failure | Respiratory, thoracic and mediastinal disorders | Vonoprazan 10 mg or 20 mg | 1 | 1,174 | |
| serious | Mallory-Weiss syndrome | Gastrointestinal disorders | Vonoprazan 10 mg or 20 mg | 1 | 1,174 | |
| serious | Oesophageal varices haemorrhage | Gastrointestinal disorders | Vonoprazan 10 mg or 20 mg | 1 | 1,174 | |
| serious | Varices oesophageal | Gastrointestinal disorders | Vonoprazan 10 mg or 20 mg | 1 | 1,174 | |
| serious | Hepatic failure | Hepatobiliary disorders | Vonoprazan 10 mg or 20 mg | 1 | 1,174 | |
| serious | Skin ulcer | Skin and subcutaneous tissue disorders | Vonoprazan 10 mg or 20 mg | 1 | 1,174 | |
| serious | Death | General disorders | Vonoprazan 10 mg or 20 mg | 1 | 1,174 | |
| serious | Platelet count decreased | Investigations | Vonoprazan 10 mg or 20 mg | 2 | 1,174 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03214081/events